As of January 2025 Iovance Biotherapeutics has a market cap of NZ$3.22 Billion. This makes Iovance Biotherapeutics the world's 4492th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 17th, 2025 the market cap of Iovance Biotherapeutics was reported to be: